| Literature DB >> 31898416 |
M Valapour1,2, C J Lehr2, M A Skeans1, J M Smith1,3, K Uccellini4, R Goff4, J Foutz4, A K Israni1,5,6, J J Snyder1,5, B L Kasiske1,6.
Abstract
The primary goal of US lung allocation policy is to ensure that candidates with the highest risk for mortality receive appropriate access to lung transplant. In 2018, 2562 lung transplants were performed in the US, reflecting a 31% increase over the past 5 years. More candidates are being listed for lung transplant, and the number of donors has increased substantially. Despite an increase of 84 lung transplants in 2018, 365 adult candidates died or became too sick to undergo transplant. In 2018, 24 new child (ages 0-11 years) candidates were added to the lung transplant waiting list. Fifteen lung transplants were performed in recipients aged 0-11 years, three in recipients aged younger than 1 year, two in recipients aged 1-5 years, and ten in recipients aged 6-11 years. Of 27 child candidates removed from the waiting list in 2018, 16 (59.3%) were removed due to undergoing transplant, six (22.2%) due to death, one (3.7%) due to improved condition, and one (3.7%) due to becoming too sick to undergo transplant. .Entities:
Keywords: zzm321990LASzzm321990; End-stage lung disease; lung allocation score; lung transplant; organ allocation; revised lung allocation score; transplant outcomes
Year: 2020 PMID： 31898416 DOI： 10.1111/ajt.15677
Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086